Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis
Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still not clear whether talc pleurodesis is more effective than other local therapies. We performed a meta-analysis to evaluate the efficacy and safety of talc pleurodesis in the management of malignant pleur...
Gespeichert in:
| Veröffentlicht in: | PloS one 2014-01, Vol.9 (1), p.e87060-e87060 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e87060 |
|---|---|
| container_issue | 1 |
| container_start_page | e87060 |
| container_title | PloS one |
| container_volume | 9 |
| creator | Xia, Huan Wang, Xiao-Juan Zhou, Qiong Shi, Huan-Zhong Tong, Zhao-Hui |
| description | Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still not clear whether talc pleurodesis is more effective than other local therapies. We performed a meta-analysis to evaluate the efficacy and safety of talc pleurodesis in the management of malignant pleural effusion.
PubMed, Embase, and Web of Science were searched for English-language studies of clinical controlled trials comparing talc pleurodesis with control therapies until August 8, 2013. Success rate and incidence of adverse events were evaluated. Relative risks were estimated using random- or fixed- effects model and statistical heterogeneity was assessed using I² test.
Twenty trials involving 1,525 patients with malignant pleural effusion were included. The success rate of talc pleurodesis was significantly higher than that of control therapies (relative risk, 1.21; 95% confidence interval, 1.01-1.45; p = 0.035) with similar adverse events. In addition, thoracoscopic talc poudrage was more effective than bedside talc slurry (relative risk, 1.12; 95% confidence interval, 1.01-1.23; p = 0.026).
The current evidences suggested the benefit for talc pleurodesis in the treatment of malignant pleural effusion. Talc pleurodesis, especially thoracoscopic talc poudrage pleurodesis, should be performed in patients with malignant pleural effusion, especially those with life-expectancy longer than one month. |
| doi_str_mv | 10.1371/journal.pone.0087060 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1492015383</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478845453</galeid><doaj_id>oai_doaj_org_article_69c73b488295474498037230423a1b25</doaj_id><sourcerecordid>A478845453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-299d34f5be3972f381bf009a076fa46417c8b22d2b9ea94dbff1a2570b53d8563</originalsourceid><addsrcrecordid>eNqNkl2L1DAUhoso7rr6D0QLgujFjPlq03ghLMuqAwsLfl6G0zSZyZA2s00qzr83dbrLVPZCcpGQ85w355y8WfYcoyWmHL_b-qHvwC13vtNLhCqOSvQgO8WCkkVJEH14dD7JnoSwRaigVVk-zk4IY7wghJxmPy-NsQrUPoeuyQMYHfe5N3kEp_Kd00PvGx1syI3v8xacXXfQxUMEXK6NGYL13fsc8lZHWEAqaZ_4p9kjAy7oZ9N-ln3_ePnt4vPi6vrT6uL8aqFKQeKCCNFQZopaU8GJoRWuDUICEC8NsJJhrqqakIbUQoNgTW0MBlJwVBe0qYqSnmUvD7o754OcZhIkZoIgnNqliVgdiMbDVu5620K_lx6s_Hvh-7WEPlrltCyF4rRmVUVEwThjokKUE4oYoYBrUiStD9NrQ93qRukupinMROeRzm7k2v-SVCBaYpQE3kwCvb8ZdIiytUFp56DTfjjUzTHBxYi--ge9v7uJWkNqwHbGp3fVKCrPGa8qVrBipJb3UGk1urUqGcjYdD9LeDtLSEzUv-MahhDk6uuX_2evf8zZ10fsRoOLm-DdEJOHwhxkB1D1PoRem7shYyRH_99OQ47-l5P_U9qL4w-6S7o1PP0DGXz92g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1492015383</pqid></control><display><type>article</type><title>Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Xia, Huan ; Wang, Xiao-Juan ; Zhou, Qiong ; Shi, Huan-Zhong ; Tong, Zhao-Hui</creator><contributor>Zulueta, Javier J.</contributor><creatorcontrib>Xia, Huan ; Wang, Xiao-Juan ; Zhou, Qiong ; Shi, Huan-Zhong ; Tong, Zhao-Hui ; Zulueta, Javier J.</creatorcontrib><description>Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still not clear whether talc pleurodesis is more effective than other local therapies. We performed a meta-analysis to evaluate the efficacy and safety of talc pleurodesis in the management of malignant pleural effusion.
PubMed, Embase, and Web of Science were searched for English-language studies of clinical controlled trials comparing talc pleurodesis with control therapies until August 8, 2013. Success rate and incidence of adverse events were evaluated. Relative risks were estimated using random- or fixed- effects model and statistical heterogeneity was assessed using I² test.
Twenty trials involving 1,525 patients with malignant pleural effusion were included. The success rate of talc pleurodesis was significantly higher than that of control therapies (relative risk, 1.21; 95% confidence interval, 1.01-1.45; p = 0.035) with similar adverse events. In addition, thoracoscopic talc poudrage was more effective than bedside talc slurry (relative risk, 1.12; 95% confidence interval, 1.01-1.23; p = 0.026).
The current evidences suggested the benefit for talc pleurodesis in the treatment of malignant pleural effusion. Talc pleurodesis, especially thoracoscopic talc poudrage pleurodesis, should be performed in patients with malignant pleural effusion, especially those with life-expectancy longer than one month.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0087060</identifier><identifier>PMID: 24475222</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Analysis ; Biology ; Breast cancer ; Cancer ; Catheters ; Clinical trials ; Complications and side effects ; Confidence intervals ; Critical care ; Dyspnea ; Hospitals ; Humans ; Iodine ; Life span ; Mathematical models ; Medical prognosis ; Medicine ; Meta-analysis ; Models, Statistical ; Ostomy ; Patients ; Pleural effusion ; Pleural Effusion, Malignant - drug therapy ; Pleurodesis - methods ; Pleurodesis - standards ; Quality of life ; Risk ; Risk assessment ; Risk management ; Safety ; Slurries ; Statistical analysis ; Studies ; Talc ; Talc - therapeutic use</subject><ispartof>PloS one, 2014-01, Vol.9 (1), p.e87060-e87060</ispartof><rights>COPYRIGHT 2014 Public Library of Science</rights><rights>2014 Xia et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2014 Xia et al 2014 Xia et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-299d34f5be3972f381bf009a076fa46417c8b22d2b9ea94dbff1a2570b53d8563</citedby><cites>FETCH-LOGICAL-c692t-299d34f5be3972f381bf009a076fa46417c8b22d2b9ea94dbff1a2570b53d8563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903610/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903610/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23847,27903,27904,53769,53771,79346,79347</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24475222$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Zulueta, Javier J.</contributor><creatorcontrib>Xia, Huan</creatorcontrib><creatorcontrib>Wang, Xiao-Juan</creatorcontrib><creatorcontrib>Zhou, Qiong</creatorcontrib><creatorcontrib>Shi, Huan-Zhong</creatorcontrib><creatorcontrib>Tong, Zhao-Hui</creatorcontrib><title>Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still not clear whether talc pleurodesis is more effective than other local therapies. We performed a meta-analysis to evaluate the efficacy and safety of talc pleurodesis in the management of malignant pleural effusion.
PubMed, Embase, and Web of Science were searched for English-language studies of clinical controlled trials comparing talc pleurodesis with control therapies until August 8, 2013. Success rate and incidence of adverse events were evaluated. Relative risks were estimated using random- or fixed- effects model and statistical heterogeneity was assessed using I² test.
Twenty trials involving 1,525 patients with malignant pleural effusion were included. The success rate of talc pleurodesis was significantly higher than that of control therapies (relative risk, 1.21; 95% confidence interval, 1.01-1.45; p = 0.035) with similar adverse events. In addition, thoracoscopic talc poudrage was more effective than bedside talc slurry (relative risk, 1.12; 95% confidence interval, 1.01-1.23; p = 0.026).
The current evidences suggested the benefit for talc pleurodesis in the treatment of malignant pleural effusion. Talc pleurodesis, especially thoracoscopic talc poudrage pleurodesis, should be performed in patients with malignant pleural effusion, especially those with life-expectancy longer than one month.</description><subject>Analysis</subject><subject>Biology</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Catheters</subject><subject>Clinical trials</subject><subject>Complications and side effects</subject><subject>Confidence intervals</subject><subject>Critical care</subject><subject>Dyspnea</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Iodine</subject><subject>Life span</subject><subject>Mathematical models</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Meta-analysis</subject><subject>Models, Statistical</subject><subject>Ostomy</subject><subject>Patients</subject><subject>Pleural effusion</subject><subject>Pleural Effusion, Malignant - drug therapy</subject><subject>Pleurodesis - methods</subject><subject>Pleurodesis - standards</subject><subject>Quality of life</subject><subject>Risk</subject><subject>Risk assessment</subject><subject>Risk management</subject><subject>Safety</subject><subject>Slurries</subject><subject>Statistical analysis</subject><subject>Studies</subject><subject>Talc</subject><subject>Talc - therapeutic use</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2L1DAUhoso7rr6D0QLgujFjPlq03ghLMuqAwsLfl6G0zSZyZA2s00qzr83dbrLVPZCcpGQ85w355y8WfYcoyWmHL_b-qHvwC13vtNLhCqOSvQgO8WCkkVJEH14dD7JnoSwRaigVVk-zk4IY7wghJxmPy-NsQrUPoeuyQMYHfe5N3kEp_Kd00PvGx1syI3v8xacXXfQxUMEXK6NGYL13fsc8lZHWEAqaZ_4p9kjAy7oZ9N-ln3_ePnt4vPi6vrT6uL8aqFKQeKCCNFQZopaU8GJoRWuDUICEC8NsJJhrqqakIbUQoNgTW0MBlJwVBe0qYqSnmUvD7o754OcZhIkZoIgnNqliVgdiMbDVu5620K_lx6s_Hvh-7WEPlrltCyF4rRmVUVEwThjokKUE4oYoYBrUiStD9NrQ93qRukupinMROeRzm7k2v-SVCBaYpQE3kwCvb8ZdIiytUFp56DTfjjUzTHBxYi--ge9v7uJWkNqwHbGp3fVKCrPGa8qVrBipJb3UGk1urUqGcjYdD9LeDtLSEzUv-MahhDk6uuX_2evf8zZ10fsRoOLm-DdEJOHwhxkB1D1PoRem7shYyRH_99OQ47-l5P_U9qL4w-6S7o1PP0DGXz92g</recordid><startdate>20140127</startdate><enddate>20140127</enddate><creator>Xia, Huan</creator><creator>Wang, Xiao-Juan</creator><creator>Zhou, Qiong</creator><creator>Shi, Huan-Zhong</creator><creator>Tong, Zhao-Hui</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140127</creationdate><title>Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis</title><author>Xia, Huan ; Wang, Xiao-Juan ; Zhou, Qiong ; Shi, Huan-Zhong ; Tong, Zhao-Hui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-299d34f5be3972f381bf009a076fa46417c8b22d2b9ea94dbff1a2570b53d8563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analysis</topic><topic>Biology</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Catheters</topic><topic>Clinical trials</topic><topic>Complications and side effects</topic><topic>Confidence intervals</topic><topic>Critical care</topic><topic>Dyspnea</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Iodine</topic><topic>Life span</topic><topic>Mathematical models</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Meta-analysis</topic><topic>Models, Statistical</topic><topic>Ostomy</topic><topic>Patients</topic><topic>Pleural effusion</topic><topic>Pleural Effusion, Malignant - drug therapy</topic><topic>Pleurodesis - methods</topic><topic>Pleurodesis - standards</topic><topic>Quality of life</topic><topic>Risk</topic><topic>Risk assessment</topic><topic>Risk management</topic><topic>Safety</topic><topic>Slurries</topic><topic>Statistical analysis</topic><topic>Studies</topic><topic>Talc</topic><topic>Talc - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xia, Huan</creatorcontrib><creatorcontrib>Wang, Xiao-Juan</creatorcontrib><creatorcontrib>Zhou, Qiong</creatorcontrib><creatorcontrib>Shi, Huan-Zhong</creatorcontrib><creatorcontrib>Tong, Zhao-Hui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xia, Huan</au><au>Wang, Xiao-Juan</au><au>Zhou, Qiong</au><au>Shi, Huan-Zhong</au><au>Tong, Zhao-Hui</au><au>Zulueta, Javier J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2014-01-27</date><risdate>2014</risdate><volume>9</volume><issue>1</issue><spage>e87060</spage><epage>e87060</epage><pages>e87060-e87060</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still not clear whether talc pleurodesis is more effective than other local therapies. We performed a meta-analysis to evaluate the efficacy and safety of talc pleurodesis in the management of malignant pleural effusion.
PubMed, Embase, and Web of Science were searched for English-language studies of clinical controlled trials comparing talc pleurodesis with control therapies until August 8, 2013. Success rate and incidence of adverse events were evaluated. Relative risks were estimated using random- or fixed- effects model and statistical heterogeneity was assessed using I² test.
Twenty trials involving 1,525 patients with malignant pleural effusion were included. The success rate of talc pleurodesis was significantly higher than that of control therapies (relative risk, 1.21; 95% confidence interval, 1.01-1.45; p = 0.035) with similar adverse events. In addition, thoracoscopic talc poudrage was more effective than bedside talc slurry (relative risk, 1.12; 95% confidence interval, 1.01-1.23; p = 0.026).
The current evidences suggested the benefit for talc pleurodesis in the treatment of malignant pleural effusion. Talc pleurodesis, especially thoracoscopic talc poudrage pleurodesis, should be performed in patients with malignant pleural effusion, especially those with life-expectancy longer than one month.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24475222</pmid><doi>10.1371/journal.pone.0087060</doi><tpages>e87060</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2014-01, Vol.9 (1), p.e87060-e87060 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_1492015383 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | Analysis Biology Breast cancer Cancer Catheters Clinical trials Complications and side effects Confidence intervals Critical care Dyspnea Hospitals Humans Iodine Life span Mathematical models Medical prognosis Medicine Meta-analysis Models, Statistical Ostomy Patients Pleural effusion Pleural Effusion, Malignant - drug therapy Pleurodesis - methods Pleurodesis - standards Quality of life Risk Risk assessment Risk management Safety Slurries Statistical analysis Studies Talc Talc - therapeutic use |
| title | Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20talc%20pleurodesis%20for%20malignant%20pleural%20effusion:%20a%20meta-analysis&rft.jtitle=PloS%20one&rft.au=Xia,%20Huan&rft.date=2014-01-27&rft.volume=9&rft.issue=1&rft.spage=e87060&rft.epage=e87060&rft.pages=e87060-e87060&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0087060&rft_dat=%3Cgale_plos_%3EA478845453%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1492015383&rft_id=info:pmid/24475222&rft_galeid=A478845453&rft_doaj_id=oai_doaj_org_article_69c73b488295474498037230423a1b25&rfr_iscdi=true |